ATE271045T1 - Sauerstoffhaltige heterocyclische verbindungen - Google Patents
Sauerstoffhaltige heterocyclische verbindungenInfo
- Publication number
- ATE271045T1 ATE271045T1 AT99968667T AT99968667T ATE271045T1 AT E271045 T1 ATE271045 T1 AT E271045T1 AT 99968667 T AT99968667 T AT 99968667T AT 99968667 T AT99968667 T AT 99968667T AT E271045 T1 ATE271045 T1 AT E271045T1
- Authority
- AT
- Austria
- Prior art keywords
- hydrogen atom
- oxygen
- containing heterocyclic
- heterocyclic compounds
- chem
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Virology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Vascular Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Dermatology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24968598 | 1998-09-03 | ||
JP8275899 | 1999-03-26 | ||
PCT/JP1999/004788 WO2000014085A1 (fr) | 1998-09-03 | 1999-09-03 | Composes heterocycliques oxygenes |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE271045T1 true ATE271045T1 (de) | 2004-07-15 |
Family
ID=26423777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99968667T ATE271045T1 (de) | 1998-09-03 | 1999-09-03 | Sauerstoffhaltige heterocyclische verbindungen |
Country Status (15)
Country | Link |
---|---|
US (1) | US6376535B2 (de) |
EP (1) | EP1110961B1 (de) |
JP (1) | JP3589985B2 (de) |
KR (1) | KR20010073099A (de) |
CN (1) | CN1109029C (de) |
AT (1) | ATE271045T1 (de) |
AU (1) | AU756878B2 (de) |
BR (1) | BR9913405A (de) |
CA (1) | CA2341890C (de) |
DE (1) | DE69918695T2 (de) |
EA (1) | EA004138B1 (de) |
ES (1) | ES2224747T3 (de) |
HU (1) | HUP0103896A3 (de) |
MX (1) | MXPA01002102A (de) |
WO (1) | WO2000014085A1 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2401489A1 (en) * | 2000-03-02 | 2001-09-07 | Ichiro Miki | Oxygen-containing heterocyclic compounds |
EP1362853A4 (de) * | 2001-01-26 | 2004-05-12 | Kyowa Hakko Kogyo Kk | Styrolderivate und verfahren zu deren herstellung |
WO2006041121A1 (ja) * | 2004-10-13 | 2006-04-20 | Kyowa Hakko Kogyo Co., Ltd. | 慢性皮膚疾患の治療および/または予防剤 |
EP1813284A1 (de) * | 2004-10-13 | 2007-08-01 | Kyowa Hakko Kogyo Co., Ltd. | Pharmazeutische zusammensetzung |
WO2006123726A1 (ja) * | 2005-05-18 | 2006-11-23 | Kyowa Hakko Kogyo Co., Ltd. | 医薬組成物 |
CA2620333A1 (en) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
EP2258358A3 (de) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenese mit Acetylcholinesterasehemmer |
EP1940389A2 (de) | 2005-10-21 | 2008-07-09 | Braincells, Inc. | Modulation von neurogenese durch pde-hemmung |
CA2625210A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
MX2008014320A (es) | 2006-05-09 | 2009-03-25 | Braincells Inc | Neurogenesis mediada por el receptor de 5-hidroxitriptamina. |
AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
MX2009002496A (es) | 2006-09-08 | 2009-07-10 | Braincells Inc | Combinaciones que contienen un derivado de 4-acilaminopiridina. |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
EP2348018A4 (de) * | 2008-09-25 | 2012-04-25 | Kyorin Seiyaku Kk | Heterocyclisches biarylderivat und dieses als wirkstoff enthaltender pde-hemmer |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
EP2563770B1 (de) | 2010-04-28 | 2016-03-23 | Leo Pharma A/S | Biarylverbindungen als pde4-inhibitoren |
EP2804603A1 (de) | 2012-01-10 | 2014-11-26 | President and Fellows of Harvard College | Betazellen-replikation für promoterverbindungen und verwendungsverfahren dafür |
US10052326B1 (en) | 2017-10-12 | 2018-08-21 | King Saud University | Antihepatotoxic agents |
CN108341807B (zh) * | 2018-02-08 | 2020-07-28 | 平顶山学院 | 含苯并二噁烷骨架的哌嗪酰胺类化合物及其制备方法和应用 |
CN110698466B (zh) * | 2019-05-20 | 2022-07-22 | 暨南大学 | 一种炭皮苯酞类化合物、组合物、制备方法及其用途 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU521225B2 (en) | 1977-04-19 | 1982-03-25 | Delalande S.A. | Alkylenedioxy phenyl derivatives |
BR8704044A (pt) | 1986-08-08 | 1988-04-05 | Mitsui Toatsu Chemicals | Pelicula de cobertura resinica inseticida |
JPS63179868A (ja) | 1987-01-21 | 1988-07-23 | Eisai Co Ltd | 1,4−ベンゾジオキサン誘導体及びその製法 |
GB9027098D0 (en) | 1990-12-13 | 1991-02-06 | Beecham Group Plc | Pharmaceuticals |
US5166367A (en) | 1991-06-21 | 1992-11-24 | American Home Products Corporation | Antipsychotic benzodioxan derivatives |
JPH07242655A (ja) | 1994-03-03 | 1995-09-19 | Taiho Yakuhin Kogyo Kk | 1,4−ベンゾジオキサン誘導体 |
JPH07242543A (ja) | 1994-03-03 | 1995-09-19 | Taiho Yakuhin Kogyo Kk | 肝疾患治療剤 |
JPH10147585A (ja) * | 1996-11-19 | 1998-06-02 | Kyowa Hakko Kogyo Co Ltd | 含酸素複素環化合物 |
ES2258775T3 (es) | 1995-05-19 | 2006-09-01 | Kyowa Hakko Kogyo Co., Ltd. | Compuestos heterociclicos que contienen oxigeno. |
EP0934291A1 (de) | 1995-10-30 | 1999-08-11 | Smithkline Beecham Corporation | Protease inhibitoren |
AU4945697A (en) | 1996-10-09 | 1998-05-05 | Novartis Ag | Solid phase synthesis of heterocyclic compounds |
DE69715769T2 (de) | 1996-11-04 | 2003-05-28 | Bayer Cropscience Sa | 1-Polyarylpyrazole als Pestizide |
EP0943613A4 (de) | 1996-11-19 | 2002-07-10 | Kyowa Hakko Kogyo Kk | Sauerstoff enthaltende heterocyclische verbindungen |
JPH1149755A (ja) | 1997-07-30 | 1999-02-23 | Nippon Kayaku Co Ltd | 新規含窒素ヘテロ環誘導体およびそれを有効成分とする殺虫殺ダニ組成物 |
AU9281298A (en) * | 1997-10-01 | 1999-04-23 | Kyowa Hakko Kogyo Co. Ltd. | Benzodioxole derivatives |
-
1999
- 1999-09-03 BR BR9913405-5A patent/BR9913405A/pt not_active IP Right Cessation
- 1999-09-03 CN CN99810602A patent/CN1109029C/zh not_active Expired - Fee Related
- 1999-09-03 JP JP2000568843A patent/JP3589985B2/ja not_active Expired - Fee Related
- 1999-09-03 EA EA200100310A patent/EA004138B1/ru not_active IP Right Cessation
- 1999-09-03 AU AU22511/00A patent/AU756878B2/en not_active Ceased
- 1999-09-03 AT AT99968667T patent/ATE271045T1/de not_active IP Right Cessation
- 1999-09-03 CA CA002341890A patent/CA2341890C/en not_active Expired - Fee Related
- 1999-09-03 HU HU0103896A patent/HUP0103896A3/hu unknown
- 1999-09-03 KR KR1020017002765A patent/KR20010073099A/ko not_active Application Discontinuation
- 1999-09-03 WO PCT/JP1999/004788 patent/WO2000014085A1/ja not_active Application Discontinuation
- 1999-09-03 EP EP99968667A patent/EP1110961B1/de not_active Expired - Lifetime
- 1999-09-03 DE DE69918695T patent/DE69918695T2/de not_active Expired - Lifetime
- 1999-09-03 ES ES99968667T patent/ES2224747T3/es not_active Expired - Lifetime
- 1999-09-03 MX MXPA01002102A patent/MXPA01002102A/es unknown
-
2001
- 2001-03-01 US US09/795,093 patent/US6376535B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69918695D1 (de) | 2004-08-19 |
CA2341890C (en) | 2006-07-18 |
MXPA01002102A (es) | 2003-02-24 |
ES2224747T3 (es) | 2005-03-01 |
US6376535B2 (en) | 2002-04-23 |
CA2341890A1 (en) | 2000-03-16 |
DE69918695T2 (de) | 2005-07-21 |
EP1110961A4 (de) | 2001-12-12 |
AU756878B2 (en) | 2003-01-23 |
HUP0103896A3 (en) | 2003-01-28 |
WO2000014085A1 (fr) | 2000-03-16 |
EA200100310A1 (ru) | 2001-10-22 |
JP3589985B2 (ja) | 2004-11-17 |
KR20010073099A (ko) | 2001-07-31 |
EP1110961A1 (de) | 2001-06-27 |
HUP0103896A2 (hu) | 2002-04-29 |
CN1109029C (zh) | 2003-05-21 |
US20010056117A1 (en) | 2001-12-27 |
BR9913405A (pt) | 2001-10-02 |
CN1317002A (zh) | 2001-10-10 |
AU2251100A (en) | 2000-03-27 |
EA004138B1 (ru) | 2004-02-26 |
EP1110961B1 (de) | 2004-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE271045T1 (de) | Sauerstoffhaltige heterocyclische verbindungen | |
ATE267814T1 (de) | Substituierte kondensierte heterocyclische verbindungen | |
DK1325910T3 (da) | Aliphatiske nitrogenholdige femleddede ringforbindelser | |
DE60230266D1 (de) | Phenylpyridincarbonyl piperazinderivate | |
UY24010A1 (es) | Nuevos pirrolocarbazoles | |
DE69824450D1 (de) | Biphenylamidin-derivate | |
DE60034577D1 (de) | In 4-stellung substituierte piperidinderivate | |
DK1559714T3 (da) | Fremgangsmåde til fremstilling af 2-alkyl-3-aminothiophenderivater og 3-aminothiophenderivater | |
DE60221250D1 (de) | Bis(5-aryl-2-pyridyl)derivate | |
EP1251129A4 (de) | Pyrimidinderivate mit antitumor-wirkung | |
EP1489076A4 (de) | Cyclisches hemiacetalderivat und dessen anwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |